EAACI Congress 2024

Back

31 May - 03 June 2024 Valencia, Spain

SAT3-1 - Ionis Pharmaceuticals – Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options

Sunday 02 Jun, 12:00 PM - 13:00 PM Valencia, Spain

Sevilla Channel Sevilla Sponsored Sessions Access On Demand Section

Upon completion of this activity, participants should be able to:

Detail unmet needs of patients living with HAE
Incorporate patient-centered strategies to promote improved adherence and acceptance of long-term prophylaxis in HAE
Evaluate recent clinical data on new and emerging agents for long-term prophylactic treatment of HAE

Supported by an educational grant from Ionis Pharmaceuticals, Inc.

12:00

Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies

13:00

Current barriers to long-term prophylaxis in HAE

13:00

New and emerging therapies for long-term prophylaxis in HAE

13:00

Patient-centered strategies for implementing long-term prophylaxis in HAE